Revenue: The sum of all revenue fields included for a company's operating activities.
VYNE Therapeutics Inc. (VYNE) had Revenue of $0.07M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$0.07M |
$-5.75M |
|
-- |
|
$0.07M |
|
$7.61M |
|
$-7.54M |
|
$1.79M |
|
$-5.75M |
|
$-5.75M |
|
$-5.75M |
|
$-5.75M |
|
$-5.75M |
|
$-5.75M |
|
$-7.54M |
|
$-7.75M |
|
42.76M |
|
42.76M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$44.34M |
|
$0.10M |
|
$0.38M |
|
$44.72M |
|
$5.84M |
|
-- |
|
-- |
|
$5.84M |
|
$38.88M |
|
$38.88M |
|
$38.88M |
|
19.77M |
|
| Cash Flow Statement Financials | |
$-22.26M |
|
$24.51M |
|
$-0.12M |
|
$19.93M |
|
$22.05M |
|
$2.12M |
|
$1.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10930.44% |
|
-10930.44% |
|
-- |
|
-8328.99% |
|
-8340.58% |
|
$-22.26M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-14.78% |
|
-14.78% |
|
-12.85% |
|
-14.78% |
|
$1.97 |
|
$-0.52 |
|
$-0.52 |
|